New York federal appeals court rules ‘pharma bro’, 40, who went to prison for fraud, cannot return to pharmaceutical industry
Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000% and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled.
A federal appeals court in New York upheld his lifetime ban from the business.
More Stories
EU microchip strategy ‘deeply disconnected from reality’, say official auditors
Aston Martin limits exports to US because of Trump tariffs
TikTok fined €530m by Irish regulator for failing to guarantee China would not access user data